We are live on ! Find out more
SIP

Stoneridge Investment Partners Portfolio holdings

AUM $152M
1-Year Est. Return 20.58%
This Fund
S&P 500
This Quarter Est. Return
+1.31%
1 Year Est. Return
+20.58%
3 Year Est. Return
+44.17%
5 Year Est. Return
+32.14%
10 Year Est. Return
+92.72%
AUM
$636M
AUM Growth
-$35.2M
Cap. Flow
-$41.5M
Cap. Flow %
-6.53%
Top 10 Hldgs %
23.23%
Holding
318
New
67
Increased
31
Reduced
120
Closed
80

Top Buys

Rank Stock Value
1
MO icon
Altria Group
MO
+$12.2M
2
MDLZ icon
Mondelez International
MDLZ
+$10.9M
3
NWL icon
Newell Brands
NWL
+$9.58M
4
MRK icon
Merck
MRK
+$9.37M
5
WY icon
Weyerhaeuser
WY
+$7.26M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$20M
2
CHTR icon
Charter Communications
CHTR
+$8.9M
3
PM icon
Philip Morris
PM
+$8.86M
4
TSN icon
Tyson Foods
TSN
+$7.78M
5
NCLH icon
Norwegian Cruise Line
NCLH
+$6.08M

Sector Composition

Rank Sector Weight
1 Financials 19.76%
2 Technology 12.98%
3 Healthcare 12.94%
4 Consumer Staples 11.54%
5 Communication Services 10.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXT icon
101
Textron
TXT
$15.4B
$1.89M 0.3%
35,066
-28,318
-45% -$1.41M
FTI icon
102
TechnipFMC
FTI
$27.3B
$1.82M 0.29%
+87,848
New +$1.76M
CL icon
103
Colgate-Palmolive
CL
$74.4B
$1.77M 0.28%
+24,331
New +$1.75M
VTRS icon
104
Viatris
VTRS
$18.9B
$1.74M 0.27%
55,593
-153,477
-73% -$5.21M
CCL icon
105
Carnival Corporation Ltd
CCL
$39.7B
$1.55M 0.24%
+24,078
New +$1.61M
SIG icon
106
Signet Jewelers
SIG
$3.76B
$1.29M 0.2%
19,321
-54,924
-74% -$3.38M
ENDP
107
DELISTED
Endo International plc
ENDP
$1.26M 0.2%
146,906
-26,100
-15% -$251K
RRR icon
108
Red Rock Resorts
RRR
$3.62B
$953K 0.15%
41,157
-18,945
-32% -$438K
MDCO
109
DELISTED
Medicines Co
MDCO
$939K 0.15%
25,351
-3,785
-13% -$140K
PBH icon
110
Prestige Consumer Healthcare
PBH
$2.6B
$862K 0.14%
17,207
-7,976
-32% -$407K
TGTX icon
111
TG Therapeutics
TGTX
$7.62B
$853K 0.13%
71,998
-32,934
-31% -$375K
TXMD icon
112
TherapeuticsMD
TXMD
$24M
$771K 0.12%
2,914
-1,001
-26% -$289K
NUVA
113
DELISTED
NuVasive, Inc.
NUVA
$727K 0.11%
+13,101
New +$867K
BGC icon
114
BGC Group
BGC
$4.89B
$658K 0.1%
70,689
-41,106
-37% -$343K
EIGI
115
DELISTED
Endurance International Group Holdings, Inc.
EIGI
$602K 0.09%
73,369
-30,007
-29% -$242K
DKS icon
116
Dick's Sporting Goods
DKS
$18.7B
$595K 0.09%
22,018
-14,392
-40% -$458K
BFAM icon
117
Bright Horizons
BFAM
$3.86B
$573K 0.09%
6,645
-4,097
-38% -$327K
IART icon
118
Integra LifeSciences
IART
$1.34B
$572K 0.09%
+11,327
New +$582K
COHR icon
119
Coherent
COHR
$74.2B
$541K 0.09%
+13,141
New +$490K
INO icon
120
Inovio Pharmaceuticals
INO
$69M
$539K 0.08%
7,078
-1,223
-15% -$91K
SYNT
121
DELISTED
Syntel Inc
SYNT
$539K 0.08%
27,437
-23,267
-46% -$425K
TLRD
122
DELISTED
Tailored Brands, Inc.
TLRD
$538K 0.08%
37,259
-8,234
-18% -$100K
HPP
123
Hudson Pacific Properties
HPP
$779M
$511K 0.08%
+2,177
New +$496K
CAR icon
124
Avis
CAR
$5.02B
$506K 0.08%
13,300
-4,724
-26% -$159K
GD icon
125
General Dynamics
GD
$106B
$501K 0.08%
2,437
– –
3 4
5
6 7

Similar funds

HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
CMMS
Comprehensive Money Management Services Coral Gables, Florida $152M AUM 20.08% 1-Year Est. Return
FHC
Forest Hill Capital Little Rock, Arkansas $152M AUM 64.38% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
II
Ibex Investors Denver, Colorado $152M AUM 19.17% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return

Stoneridge Investment Partners's Q3 2017 Portfolio in Review

As of Q3 2017, Stoneridge Investment Partners held 318 positions worth $636M, down 5.2% from $671M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Stoneridge Investment Partners withdrew a net $41.5M in Q3 2017, closing 80 positions and reducing 120 holdings. Its most notable exit was Gilead Sciences, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Stoneridge Investment Partners opened a new position in Altria Group worth $11.6M.

  • Stoneridge Investment Partners's largest Q3 2017 buy was Altria Group: 183,060 shares worth $11.6M.
  • Stoneridge Investment Partners added most to Apple in Q3 2017, an estimated $4.06M increase.
  • Stoneridge Investment Partners's biggest Q3 2017 reduction was Tyson Foods, cutting an estimated $7.78M.
  • Stoneridge Investment Partners fully exited Gilead Sciences in Q3 2017, selling an estimated $20M.
  • Stoneridge Investment Partners's ten largest holdings make up 23% of its $636M portfolio in Q3 2017.
  • Stoneridge Investment Partners opened 67 new positions and closed 80 in Q3 2017.
  • Stoneridge Investment Partners's portfolio value fell 5.2% quarter-over-quarter to $636M.

Based on Stoneridge Investment Partners's 13F filing for Q3 2017, filed 2 Nov 2017.